Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.84 |
| ▸ | CNR1 | P21554 | 5/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13926164 | 0.92 | CNR2 (0.88) | CNR2CNR1 | |
| Sr-144528 SCHEMBL8039660 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL8137029 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL1546003 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL19551517 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL8313006 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL1432281 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| Sr-144528 SCHEMBL14355050 | 0.91 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL13883231 | 0.91 | CNR2 (0.80) | CNR2CNR1 | |
| SCHEMBL13883199 | 0.90 | CNR2 (0.78) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367714-B2 | Cannabinoid receptor targeted agent | VANDERBILT UNIVERSITY (US) | 2013-02-05 | — | — | US | disclosed |
| US-20090105128-A1 | CANNABINOID RECEPTOR TARGETED AGENT | VANDERABILT UNIVERSITY | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105128-A1 | CANNABINOID RECEPTOR TARGETED AGENT | CNR1, CNR2, NPY1R | CNR2 2/4885CNR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.